PDF herunterladen
Clin Colon Rectal Surg 2011; 24(3): 142-148
DOI: 10.1055/s-0031-1285998
© Thieme Medical Publishers

Epidermoid Cancer of the Anal Canal

Shawn P. Webb1 , Chong S. Lee1
  • 1Division of Colon and Rectal Surgery, Henry Ford Hospital, Detroit, Michigan
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
26. August 2011 (online)

Auch verfügbar auf
    Lizenzen und Reprints

ABSTRACT

Anal canal cancer is a rare cancer with incidence that continues to rise. This has been in large part due to increased prevalence of immunosuppressed conditions such as organ transplantation and human immunodeficiency virus along with transmission of the human papillomavirus. Identification of high-risk groups and close monitoring of these groups can help to detect earlier stages of cancer. Chemoradiation therapy remains the mainstay of treatment with excellent outcomes. Surgery for anal canal carcinoma remains as a salvage technique for failed chemoradiation or recurrent disease.

KEYWORDS

Epidermoid carcinoma - squamous carcinoma - anal canal

REFERENCES

  • 1 Zaleski L, Turiansky G W. Squamous cell carcinoma of the anal canal.  Cutis. 2010;  85 (3) 143-145
    PubMedSuche in Google Scholar
  • 2 Bower M, Powles T, Newsom-Davis T et al.. HIV-associated anal cancer: has highly active antiretroviral therapy reduced the incidence or improved the outcome?.  J Acquir Immune Defic Syndr. 2004;  37 (5) 1563-1565
    CrossrefPubMedSuche in Google Scholar
  • 3 National Cancer Institute. Anal Cancer Treatment. Available at: http://www.cancer.gov/cancertopics/pdq/treatment/anal/HealthProfessional Accessed November 7, 2010
    Suche in Google Scholar
  • 4 Gervaz P, Buchs N, Morel P. Diagnosis and management of anal cancer.  Curr Gastroenterol Rep. 2008;  10 (5) 502-506
    CrossrefPubMedSuche in Google Scholar
  • 5 Wolf B T, Fleshman J W, Beck D E, Pemberton J H, Wexner S D. The ASCRS Textbook of Colon and Rectal Surgery. New York: Springer; 2011
    Suche in Google Scholar
  • 6 Mendenhall W M, Zlotecki R A, Vauthey J N, Copeland E M. Squamous cell carcinoma of the anal margin treated with radiotherapy.  Oncology (Williston Park). 1996;  10 (12) 1843-1848
    PubMedSuche in Google Scholar
  • 7 DeVita V T, Lawrence T S, Rosenberg S A, DePinho R A, Weinberg R A. DeVita, Hellman, and Rosenberg's Cancer: Principles & Practice of Oncology, Volume 1. Philadelphia: Lippincott Williams & Wilkins; 2008
    Suche in Google Scholar
  • 8 Altekruse S F, Kosary C L, Krapcho M et al, Eds.. SEER Cancer Statistics Review, 1975–2007. Bethesda, MD: National Cancer Institute. Available at: http://seer.cancer.gov/csr/1975_2007/ Accessed November 7, 2010
    Suche in Google Scholar
  • 9 Frisch M, Glimelius B, van den Brule A J et al.. Sexually transmitted infection as a cause of anal cancer.  N Engl J Med. 1997;  337 (19) 1350-1358
    CrossrefPubMedSuche in Google Scholar
  • 10 Palefsky J M. Anal human papillomavirus infection and anal cancer in HIV-positive individuals: an emerging problem.  AIDS. 1994;  8 (3) 283-295
    CrossrefPubMedSuche in Google Scholar
  • 11 Piketty C, Darragh T M, Heard I et al.. High prevalence of anal squamous intraepithelial lesions in HIV-positive men despite the use of highly active antiretroviral therapy.  Sex Transm Dis. 2004;  31 (2) 96-99
    PubMedSuche in Google Scholar
  • 12 Abramowitz L, Benabderrahmane D, Ravaud P et al.. Anal squamous intraepithelial lesions and condyloma in HIV-infected heterosexual men, homosexual men and women: prevalence and associated factors.  AIDS. 2007;  21 (11) 1457-1465
    CrossrefPubMedSuche in Google Scholar
  • 13 Arends M J, Benton E C, McLaren K M, Stark L A, Hunter J A, Bird C C. Renal allograft recipients with high susceptibility to cutaneous malignancy have an increased prevalence of human papillomavirus DNA in skin tumours and a greater risk of anogenital malignancy.  Br J Cancer. 1997;  75 (5) 722-728
    CrossrefPubMedSuche in Google Scholar
  • 14 Hogg M E, Popowich D A, Wang E C, Kiel K D, Stryker S J, Halverson A L. HIV and anal cancer outcomes: a single institution's experience.  Dis Colon Rectum. 2009;  52 (5) 891-897
    CrossrefPubMedSuche in Google Scholar
  • 15 Madkan V K, Cook-Norris R H, Steadman M C, Arora A, Mendoza N, Tyring S K. The oncogenic potential of human papillomaviruses: a review on the role of host genetics and environmental cofactors.  Br J Dermatol. 2007;  157 (2) 228-241
    CrossrefPubMedSuche in Google Scholar
  • 16 De Vuyst H, Clifford G M, Nascimento M C, Madeleine M M, Franceschi S. Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis.  Int J Cancer. 2009;  124 (7) 1626-1636
    CrossrefPubMedSuche in Google Scholar
  • 17 Palefsky J M, Holly E A, Hogeboom C J, Berry J M, Jay N, Darragh T M. Anal cytology as a screening tool for anal squamous intraepithelial lesions.  J Acquir Immune Defic Syndr Hum Retrovirol. 1997;  14 (5) 415-422
    CrossrefPubMedSuche in Google Scholar
  • 18 Cranston R D, Hart S D, Gornbein J A, Hirschowitz S L, Cortina G, Moe A A. The prevalence, and predictive value, of abnormal anal cytology to diagnose anal dysplasia in a population of HIV-positive men who have sex with men.  Int J STD AIDS. 2007;  18 (2) 77-80
    CrossrefPubMedSuche in Google Scholar
  • 19 Devaraj B, Cosman B C. Expectant management of anal squamous dysplasia in patients with HIV.  Dis Colon Rectum. 2006;  49 (1) 36-40
    CrossrefPubMedSuche in Google Scholar
  • 20 Chang G J, Berry J M, Jay N, Palefsky J M, Welton M L. Surgical treatment of high-grade anal squamous intraepithelial lesions: a prospective study.  Dis Colon Rectum. 2002;  45 (4) 453-458
    CrossrefPubMedSuche in Google Scholar
  • 21 UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research . Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin.  Lancet. 1996;  348 (9034) 1049-1054
    CrossrefPubMedSuche in Google Scholar
  • 22 Cotter S E, Grigsby P W, Siegel B A et al.. FDG-PET/CT in the evaluation of anal carcinoma.  Int J Radiat Oncol Biol Phys. 2006;  65 (3) 720-725
    CrossrefPubMedSuche in Google Scholar
  • 23 Trautmann T G, Zuger J H. Positron emission tomography for pretreatment staging and posttreatment evaluation in cancer of the anal canal.  Mol Imaging Biol. 2005;  7 (4) 309-313
    CrossrefPubMedSuche in Google Scholar
  • 24 Bilimoria K Y, Bentrem D J, Rock C E, Stewart A K, Ko C Y, Halverson A. Outcomes and prognostic factors for squamous-cell carcinoma of the anal canal: analysis of patients from the National Cancer Data Base.  Dis Colon Rectum. 2009;  52 (4) 624-631
    CrossrefPubMedSuche in Google Scholar
  • 25 Wieland U, Brockmeyer N H, Weissenborn S J et al.. Imiquimod treatment of anal intraepithelial neoplasia in HIV-positive men.  Arch Dermatol. 2006;  142 (11) 1438-1444
    CrossrefPubMedSuche in Google Scholar
  • 26 Kreuter A, Potthoff A, Brockmeyer N H German Competence Network HIV/AIDS et al. Imiquimod leads to a decrease of human papillomavirus DNA and to a sustained clearance of anal intraepithelial neoplasia in HIV-infected men.  J Invest Dermatol. 2008;  128 (8) 2078-2083
    CrossrefPubMedSuche in Google Scholar
  • 27 Richel O, Wieland U, de Vries H J et al.. Topical 5-fluorouracil treatment of anal intraepithelial neoplasia in human immunodeficiency virus-positive men.  Br J Dermatol. 2010;  163 (6) 1301-1307 10.1111/j.1365-2133.2010.09982.x [Epub ahead of print]
    CrossrefPubMedSuche in Google Scholar
  • 28 Nigro N D, Seydel H G, Considine B, Vaitkevicius V K, Leichman L, Kinzie J J. Combined preoperative radiation and chemotherapy for squamous cell carcinoma of the anal canal.  Cancer. 1983;  51 (10) 1826-1829
    CrossrefPubMedSuche in Google Scholar
  • 29 Boman B M, Moertel C G, O'Connell M J et al.. Carcinoma of the anal canal. A clinical and pathologic study of 188 cases.  Cancer. 1984;  54 (1) 114-125
    CrossrefPubMedSuche in Google Scholar
  • 30 Dougherty B G, Evans H L. Carcinoma of the anal canal: a study of 79 cases.  Am J Clin Pathol. 1985;  83 (2) 159-164
    PubMedSuche in Google Scholar
  • 31 Greenall M J, Quan S H, Urmacher C, DeCosse J J. Treatment of epidermoid carcinoma of the anal canal.  Surg Gynecol Obstet. 1985;  161 (6) 509-517
    PubMedSuche in Google Scholar
  • 32 Bartelink H, Roelofsen F, Eschwege F et al.. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups.  J Clin Oncol. 1997;  15 (5) 2040-2049
    PubMedSuche in Google Scholar
  • 33 Gunderson L L, Winter K A, Ajani J A et al.. Intergroup RTOG 9811 phase III comparison of chemoradiation with 5-FU and mitomycin vs 5-FU and cisplatin for anal canal carcinoma: impact on disease-free, overall and colostomy-free survival.  [abstract] Int J Radiat Oncol Biol Phys. 2006;  66 A43-S24
    CrossrefPubMedSuche in Google Scholar
  • 34 Ajani J A, Winter K A, Gunderson L L et al.. Intergroup RTOG 98–11: a phase III randomized study of 5-fluoruracil (5-FU), mitomycin, and radiotherapy versus 5-fluorouracil, cisplatin and radiotherapy in carcinoma of the anal canal.  J Clin Oncol. 2006;  24 A4009
    PubMedSuche in Google Scholar
  • 35 Provencher S, Oehler C, Lavertu S, Jolicoeur M, Fortin B, Donath D. Quality of life and tumor control after short split-course chemoradiation for anal canal carcinoma.  Radiat Oncol. 2010;  5 41
    CrossrefPubMedSuche in Google Scholar
  • 36 Doci R, Zucali R, La Monica G et al.. Primary chemoradiation therapy with fluorouracil and cisplatin for cancer of the anus: results in 35 consecutive patients.  J Clin Oncol. 1996;  14 (12) 3121-3125
    PubMedSuche in Google Scholar
  • 37 Peiffert D, Seitz J F, Rougier P et al.. Preliminary results of a phase II study of high-dose radiation therapy and neoadjuvant plus concomitant 5-fluorouracil with CDDP chemotherapy for patients with anal canal cancer: a French cooperative study.  Ann Oncol. 1997;  8 (6) 575-581
    CrossrefPubMedSuche in Google Scholar
  • 38 James R, Wan S, Glynne-Jones R et al.. A randomized trial of chemoradiation using mitomycin or cisplatin, with or without maintenance cisplatin/5FU on squamous cell carcinoma of the anus (ACT II).  J Clin Oncol. 27 18s 2009;  (suppl; abstr LBA4009)
    CrossrefPubMedSuche in Google Scholar
  • 39 Engineer R, Mallik S, Mahantshetty U, Shrivastava S. Impact of radiation dose on locoregional control and survival on squamous cell carcinoma of anal canal.  Radiother Oncol. 2010;  95 (3) 283-287
    CrossrefPubMedSuche in Google Scholar
  • 40 Ferrigno R, Nakamura R A, Dos Santos Novaes P E et al.. Radiochemotherapy in the conservative treatment of anal canal carcinoma: retrospective analysis of results and radiation dose effectiveness.  Int J Radiat Oncol Biol Phys. 2005;  61 (4) 1136-1142
    CrossrefPubMedSuche in Google Scholar
  • 41 Conroy T, Ducreux M, Lemanski C et al.. Treatment intensification by induction chemotherapy (ICT) and radiation dose escalation in locally advanced squamous cell anal canal carcinoma (LAAC): definitive analysis of the intergroup ACCORD 03 trial.  J Clin Oncol. 2009;  27 4033
    PubMedSuche in Google Scholar
  • 42 Graf R, Wust P, Hildebrandt B et al.. Impact of overall treatment time on local control of anal cancer treated with radiochemotherapy.  Oncology. 2003;  65 (1) 14-22
    CrossrefPubMedSuche in Google Scholar
  • 43 Kim J H, Sarani B, Orkin B A et al.. HIV-positive patients with anal carcinoma have poorer treatment tolerance and outcome than HIV-negative patients.  Dis Colon Rectum. 2001;  44 (10) 1496-1502
    CrossrefPubMedSuche in Google Scholar
  • 44 Edelman S, Johnstone P A. Combined modality therapy for HIV-infected patients with squamous cell carcinoma of the anus: outcomes and toxicities.  Int J Radiat Oncol Biol Phys. 2006;  66 (1) 206-211
    CrossrefPubMedSuche in Google Scholar
  • 45 Oehler-Jänne C, Huguet F, Provencher S et al.. HIV-specific differences in outcome of squamous cell carcinoma of the anal canal: a multicentric cohort study of HIV-positive patients receiving highly active antiretroviral therapy.  J Clin Oncol. 2008;  26 (15) 2550-2557
    CrossrefPubMedSuche in Google Scholar
  • 46 Wexler A, Berson A M, Goldstone S E et al.. Invasive anal squamous-cell carcinoma in the HIV-positive patient: outcome in the era of highly active antiretroviral therapy.  Dis Colon Rectum. 2008;  51 (1) 73-81
    CrossrefPubMedSuche in Google Scholar
  • 47 Hoffman R, Welton M L, Klencke B, Weinberg V, Krieg R. The significance of pretreatment CD4 count on the outcome and treatment tolerance of HIV-positive patients with anal cancer.  Int J Radiat Oncol Biol Phys. 1999;  44 (1) 127-131
    CrossrefPubMedSuche in Google Scholar
  • 48 Charnley N, Choudhury A, Chesser P, Cooper R A, Sebag-Montefiore D. Effective treatment of anal cancer in the elderly with low-dose chemoradiotherapy.  Br J Cancer. 2005;  92 (7) 1221-1225
    CrossrefPubMedSuche in Google Scholar
  • 49 Das P, Cantor S B, Parker C L et al.. Long-term quality of life after radiotherapy for the treatment of anal cancer.  Cancer. 2010;  116 (4) 822-829
    CrossrefPubMedSuche in Google Scholar
  • 50 Longo W E, Vernava III A M, Wade T P, Coplin M A, Virgo K S, Johnson F E. Recurrent squamous cell carcinoma of the anal canal. Predictors of initial treatment failure and results of salvage therapy.  Ann Surg. 1994;  220 (1) 40-49
    CrossrefPubMedSuche in Google Scholar
  • 51 Flam M, John M, Pajak T F et al.. Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study.  J Clin Oncol. 1996;  14 (9) 2527-2539
    PubMedSuche in Google Scholar
  • 52 Akbari R P, Paty P B, Guillem J G et al.. Oncologic outcomes of salvage surgery for epidermoid carcinoma of the anus initially managed with combined modality therapy.  Dis Colon Rectum. 2004;  47 (7) 1136-1144
    CrossrefPubMedSuche in Google Scholar
  • 53 Allal A S, Laurencet F M, Reymond M A, Kurtz J M, Marti M C. Effectiveness of surgical salvage therapy for patients with locally uncontrolled anal carcinoma after sphincter-conserving treatment.  Cancer. 1999;  86 (3) 405-409
    CrossrefPubMedSuche in Google Scholar
  • 54 Ellenhorn J D, Enker W E, Quan S H. Salvage abdominoperineal resection following combined chemotherapy and radiotherapy for epidermoid carcinoma of the anus.  Ann Surg Oncol. 1994;  1 (2) 105-110
    CrossrefPubMedSuche in Google Scholar
  • 55 Mullen J T, Rodriguez-Bigas M A, Chang G J et al.. Results of surgical salvage after failed chemoradiation therapy for epidermoid carcinoma of the anal canal.  Ann Surg Oncol. 2007;  14 (2) 478-483
    CrossrefPubMedSuche in Google Scholar
  • 56 Schiller D E, Cummings B J, Rai S et al.. Outcomes of salvage surgery for squamous cell carcinoma of the anal canal.  Ann Surg Oncol. 2007;  14 (10) 2780-2789
    CrossrefPubMedSuche in Google Scholar
  • 57 Clark M A, Hartley A, Geh J I. Cancer of the anal canal.  Lancet Oncol. 2004;  5 (3) 149-157
    CrossrefPubMedSuche in Google Scholar
  • 58 Farid H, O'Connell T X. Methods to decrease the morbidity of abdominoperineal resection.  Am Surg. 1995;  61 (12) 1061-1064
    PubMedSuche in Google Scholar
  • 59 Papaconstantinou H T, Bullard K M, Rothenberger D A, Madoff R D. Salvage abdominoperineal resection after failed Nigro protocol: modest success, major morbidity.  Colorectal Dis. 2006;  8 (2) 124-129
    CrossrefPubMedSuche in Google Scholar
  • 60 Shibata D, Hyland W, Busse P et al.. Immediate reconstruction of the perineal wound with gracilis muscle flaps following abdominoperineal resection and intraoperative radiation therapy for recurrent carcinoma of the rectum.  Ann Surg Oncol. 1999;  6 (1) 33-37
    CrossrefPubMedSuche in Google Scholar
  • 61 Tei T M, Stolzenburg T, Buntzen S, Laurberg S, Kjeldsen H. Use of transpelvic rectus abdominis musculocutaneous flap for anal cancer salvage surgery.  Br J Surg. 2003;  90 (5) 575-580
    CrossrefPubMedSuche in Google Scholar
  • 62 Engstrom P F, Arnoletti J P, Benson III A B et al. NCCN. NCCN clinical practice guidelines in oncology. Anal carcinoma.  J Natl Compr Canc Netw. 2010;  8 (1) 106-120
    PubMedSuche in Google Scholar
  • 63 Magdeburg B, Fried M, Meyenberger C. Endoscopic ultrasonography in the diagnosis, staging, and follow-up of anal carcinomas.  Endoscopy. 1999;  31 (5) 359-364
    Thieme ConnectPubMedSuche in Google Scholar
  • 64 Martellucci J, Naldini G, Colosimo C, Cionini L, Rossi M. Accuracy of endoanal ultrasound in the follow-up assessment for squamous cell carcinoma of the anal canal treated with radiochemotherapy.  Surg Endosc. 2009;  23 (5) 1054-1057
    CrossrefPubMedSuche in Google Scholar
  • 65 Lund J A, Sundstrom S H, Haaverstad R, Wibe A, Svinsaas M, Myrvold H E. Endoanal ultrasound is of little value in follow-up of anal carcinomas.  Dis Colon Rectum. 2004;  47 (6) 839-842
    CrossrefPubMedSuche in Google Scholar
  • 66 Koh D M, Dzik-Jurasz A, O'Neill B, Tait D, Husband J E, Brown G. Pelvic phased-array MR imaging of anal carcinoma before and after chemoradiation.  Br J Radiol. 2008;  81 (962) 91-98
    CrossrefPubMedSuche in Google Scholar
  • 67 Mistrangelo M E, Pelosi E, Bellò M et al.. Comparison of positron emission tomography scanning and sentinel node biopsy in the detection of inguinal node metastases in patients with anal cancer.  Int J Radiat Oncol Biol Phys. 2010;  77 (1) 73-78
    CrossrefPubMedSuche in Google Scholar

Chong S LeeM.D. 

Division of Colon and Rectal Surgery, Henry Ford Hospital

2799 W. Grand Blvd., Detroit, MI 48202

eMail: clee1@hfhs.org